Key facts
- It has raised $50K; the latest was Angel (individual) ($50K) in May 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for NOVA Genomics
- ·The full record, as it builds
Funding rounds
No funding rounds for NOVA Genomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NOVA Genomics
Developer of preimplantation genetic testing designed to provide clinically meaningful insights accessible to every IVF journey. The company offers advanced genetic testing to families in need of PGT-SR and PGT-M testing for inherited conditions, enabling patients and IVF providers to navigate the complexities of genetic testing through informed decision-making.
- Sector
- Healthcare
- HQ
- Manassas, VA, United States
- Founded
- 2025
- Employees
- 3
- Website
- novagenomics.org/
- Ownership
- Privately Held (backing)
NOVA Genomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NOVA Genomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NOVA Genomics in its N-PORT filings yet. We sweep new filings monthly.